1. Factors associated with non-use and sub-target dosing of medical therapy for heart failure with reduced ejection fraction

   • Stephen J. Greene
   • Xi Tan
   • Javed Butler

   ReviewPaper 20 January 2021 Pages: 741 - 753

   

2. Weighing in on heart failure: the potential impact of bariatric surgery

   • Tanuka Datta
   • Andrew J. Lee
   • David J. Whellan

   ReviewPaper Open access 25 January 2021 Pages: 755 - 766

   

3. Noncardiac comorbidity clustering in heart failure: an overlooked aspect with potential therapeutic door

   • Alberto Palazzuoli
   • Gaetano Ruocco
   • Edoardo Gronda

   ReviewPaper 08 May 2020 Pages: 767 - 778

   

4. Assessing the future risks of subsequent pregnancies in peripartum cardiomyopathy

   • Zachary Port
   • Zaid Ammari
   • Behnam Bozorgnia

   ReviewPaper 12 January 2021 Pages: 779 - 784

   

5. Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness

   • Jose N. Nativi-Nicolau
   • Chafic Karam
   • Mathew S. Maurer

   ReviewPaper Open access 20 February 2021 Pages: 785 - 793

   

6. Effects of chronotropic incompetence on exercise capacity in people with heart failure versus age-matched controls

   • Smart NA
   • Clark H
   • Pearson MJ

   ReviewPaper 19 April 2021 Pages: 795 - 809

   

7. The efficacy of bone marrow mononuclear stem cell transplantation in patients with non-ischemic dilated cardiomyopathy—a meta analysis

   • Nso Nso
   • Kaveh Rezaei Bookani
   • Robert Gordon

   ReviewPaper 15 February 2021 Pages: 811 - 820

   

8. Lung ultrasound–guided management to reduce hospitalization in chronic heart failure: a systematic review and meta-analysis

   • Mohammed Mhanna
   • Azizullah Beran
   • Ehab A Eltahawy

   ReviewPaper 09 April 2021 Pages: 821 - 826

   

9. Global longitudinal strain predicts responders after cardiac resynchronization therapy—a systematic review and meta-analysis

   • George Bazoukis
   • Costas Thomopoulos
   • Petros Nihoyannopoulos

   ReviewPaper 30 March 2021 Pages: 827 - 836

   

10. The common characteristics and mutual effects of heart failure and atrial fibrillation: initiation, progression, and outcome of the two aging-related heart diseases

    • Yuxia Pan
    • Li Xu
    • Yuanfeng Gao

    ReviewPaper 25 March 2021 Pages: 837 - 847

    

11. Clinical comparison of V122I genotypic variant of transthyretin amyloid cardiomyopathy with wild-type and other hereditary variants: a systematic review

    • Amandeep Goyal
    • Shubham Lahan
    • Zubair Shah

    OriginalPaper 25 March 2021 Pages: 849 - 856

    

12. Prognostic impact of antiplatelet therapy in Takotsubo syndrome: a systematic review and meta-analysis of the literature

    • Francesca Rizzetto
    • Micaela Lia
    • Flavio Luciano Ribichini

    ReviewPaper Open access 29 March 2021 Pages: 857 - 868

    

13. Maintenance immunosuppression in heart transplantation: insights from network meta-analysis of various immunosuppression regimens

    • Hiroki Ueyama
    • Toshiki Kuno
    • Alexandros Briasoulis

    ReviewPaper 18 May 2020 Pages: 869 - 877

    

14. Outcomes of percutaneous temporary biventricular mechanical support: a systematic review

    • Matthew P. Weber
    • Thomas J. O’Malley
    • Vakhtang Tchantchaleishvili

    ReviewPaper 26 May 2020 Pages: 879 - 890

    

15. Echocardiography for left ventricular assist device implantation and evaluation: an indispensable tool

    • Carlotta Sciaccaluga
    • Hatem Soliman-Aboumarie
    • Matteo Cameli

    ReviewPaper 11 January 2021 Pages: 891 - 902

    

16. Complications in children with ventricular assist devices: systematic review and meta-analyses

    • Andrea Nicola George
    • Tain-Yen Hsia
    • Selim Bozkurt

    ReviewPaper 04 March 2021 Pages: 903 - 913

    

17. Contemporary device management of cardiogenic shock following acute myocardial infarction

    • Tariq Suleiman
    • Alexander Scott
    • Vijay Kunadian

    ReviewPaper 03 March 2021 Pages: 915 - 925

    

18. Mechanical circulatory support in patients with cardiogenic shock not secondary to cardiotomy: a network meta-analysis

    • Stefano Benenati
    • Matteo Toma
    • Italo Porto

    ReviewPaper Open access 06 March 2021 Pages: 927 - 934

    

19. SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms

    • Maja Nikolic
    • Vladimir Zivkovic
    • Vladimir Jakovljevic

    ReviewPaper 03 February 2021 Pages: 935 - 949

20. SGLT2 inhibitors and cardiovascular and renal outcomes: a meta-analysis and trial sequential analysis

    • Mahmoud Barbarawi
    • Ahmad Al-abdouh
    • Kai Chen

    ReviewPaper 23 February 2021 Pages: 951 - 960

    

21. SGLT2 inhibitors break the vicious circle between heart failure and insulin resistance: targeting energy metabolism

    • Xiaodan Wang
    • Jingyu Ni
    • Guanwei Fan

    ReviewPaper 12 March 2021 Pages: 961 - 980

    

22. Letter to the Editor regarding the article “SGLT2 inhibitors and cardiovascular and renal outcomes: a meta‑analysis and trial sequential analysis”

    • Mei Qiu
    • Liang-Liang Ding
    • Hai-Rong Zhou

    Letter 04 May 2021 Pages: 981 - 982

23. Reply to the letter to the editor

    • Amin Yehya
    • Michelle M. Kittleson

    EditorialNotes 02 March 2022 Pages: 983 - 983

24. Letter to the editor to update the article “Remote monitoring for heart failure using implantable devices: a systematic review, meta-analysis, and meta-regression of randomized controlled trials”

    • Alexander G. Hajduczok
    • Samer N. Muallem
    • John P. Boehmer

    ReviewPaper 09 November 2021 Pages: 985 - 987

    

25. Letter to the Editor

    • Carroll Foley
    • Hunter Groninger
    • Anirudh Rao

    EditorialNotes 01 March 2022 Pages: 989 - 989

26. Correction to: Is it time to revisit ICD indications?

    • Amin Yehya
    • Jonathan D. Davis
    • Nasrien E. Ibrahim

    Author Correction 15 February 2022 Pages: 991 - 991